Cocaine Abuse and ADHD - 10

• Status: Completed
• Trial end date: 1998-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and efficacy of buproprion in treating individuals with adult attention-deficit hyperactivity disorder (ADHD) and cocaine dependence.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA)
• Collaborator: New York State Psychiatric Institute
• Treatments: Cocaine; Flupenthixol; Flupenthixol decanoate

Criteria

Please contact site for information.